Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

GSK to produce two new vaccines at Saint-Amand-les-Eaux site

21 Sep 2016 | Front page, Health Nutrition, A region on the move

For years GSK’s plant in Northern France has worked to raise its profile as one of the pharmaceutical group’s strategic assets. Mission accomplished: two new vaccines will soon be rolling off its production lines, spearheading a drive to conquer the US market by 2018.

Plant in Northern France plays key strategic role

Since 2015, GlaxoSmithKline (GSK) has invested over €13 million to upgrade production lines and ramp up output at its Saint-Amand-les-Eaux facility, as part of the group’s global strategy. Now Saint-Amand has been selected from among GSK’s 18 sites worldwide to produce new vaccines for shingles and malaria. 

“This new project show that we’ve become a pacesetter within GSK Group,” says Manufacturing Site Director Géraldine Vetterhoeffer, who has just been named Vice-President Quality for GSK Worldwide.

The investments point to a bright future for the plant, which is set on conquering the American market by 2018.

Made in France, exported worldwide

Nearly 40% of the world’s children are treated with a vaccine made by GSK—an achievement that Ms. Vetterhoeffer readily points out. “My greatest source of pride is that our products have such a powerful impact around the world,” she says. 

GSK currently exports 70% of the products it makes in France.

Major investment 

GSK has operated in Saint-Amand-les-Eaux since 2011, putting a total of €600 million into the plant. That’s the largest industrial investment made by a foreign pharmaceutical company in France over the past 20 years, and it has had huge economic implications for Northern France: the site currently has 800 employees, and sales are expected to rise 20% to 30% in the future. 

Source: Usine Nouvelle / La Voix du Nord 

Back to news

News

Coca Cola, a long-standing presence in Hauts-de-France

It is 30 years this year since Coca Cola moved to Socx, near Dunkirk. The development and investment which has taken place in those 30 years have made the plant one of the brand’s top three production sites in...

Cybersecurity: Vade Secure brought into the American fold

In Lille (Hauts-de-France), the cyber security start-up Vade Secure has raised 70 million euros from an American fund to accelerate its international expansion.

All news